Asset Dedication’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.87K Hold
25
– – ﹤0.01% 1026
2026
Q2
$1.98K Hold
25
– – ﹤0.01% 1040
2026
Q1
$2.15K Hold
25
– – ﹤0.01% 961
2025
Q4
$2.18K Hold
25
– – ﹤0.01% 1000
2025
Q3
$1.43K Hold
25
– – ﹤0.01% 1043
2025
Q2
$1.48K Hold
25
– – ﹤0.01% 1055
2025
Q1
$1.83K Hold
25
– – ﹤0.01% 968
2024
Q4
$2.07K Buy
+25
New +$1.97K ﹤0.01% 969
2023
Q1
– Sell
-9
Closed -$1K – 998
2022
Q4
$1K Hold
9
– – ﹤0.01% 929
2022
Q3
$1K Buy
+9
New +$542 ﹤0.01% 881
2022
Q2
– Sell
-9
Closed -$1K – 669
2022
Q1
$1K Buy
+9
New +$626 ﹤0.01% 920

Other funds holding GMED

Asset Dedication's GMED Position: Q3 2026 in Review

Asset Dedication held its Globus Medical (GMED) position steady in Q3 2026 at 25 shares worth $1.87K. The position accounts for ﹤0.01% of the portfolio, ranked #1026.

Asset Dedication first reported a position in GMED in Q1 2022 and has held it in 11 quarters since. The position peaked at $2.18K in Q4 2025. 512 funds tracked by Wall St. Rank hold GMED as of Q3 2026.

  • Asset Dedication held 25 shares of Globus Medical worth $1.87K as of Q3 2026.
  • Asset Dedication left its Globus Medical share count unchanged in Q3 2026.
  • Globus Medical made up ﹤0.01% of Asset Dedication's portfolio in Q3 2026, its #1026 holding.
  • Asset Dedication first reported a position in Globus Medical in Q1 2022 and has held it in 11 quarters since.
  • Asset Dedication's Globus Medical position peaked at $2.18K in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.

Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.